Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bergman

Showing results (141-150 of 175) with videos related to

Pageof 18
Sort By:
BMJ Open|July 6, 2021
Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19Anders Kjellberg, Johan Douglas, Michael T Pawlik, et al.
Ebiomedicine|February 20, 2026
High-dimensional single-cell analyses reveal neutrophil heterogeneity in guttate psoriasisAvinash Padhi, Anoop T Ambikan, Panagiotis Andriopoulos, et al.
Scientific Reports|November 24, 2020
Insights in the regulation of trimetylamine N-oxide production using a comparative biomimetic approach suggest a metabolic switch in hibernating bearsThomas Ebert, Johanna Painer, Peter Bergman, et al.
Infectious Diseases (London, England)|September 25, 2024
Risk of COVID-19 hospitalisation by HIV-status and SARS-CoV-2 vaccination status during pre- and post-Omicron era in a national register-based cohort study in SwedenIsabela Killander Möller, Pontus Hedberg, Philippe Wagner, et al.
Journal of Clinical Immunology|September 1, 2022
Three Adult Cases of STAT1 Gain-of-Function with Chronic Mucocutaneous Candidiasis Treated with JAK InhibitorsEmilie W Borgström, Marie Edvinsson, Lucía P Pérez, et al.
Frontiers in Immunology|January 27, 2023
Persistence of salivary antibody responses after COVID-19 vaccination is associated with oral microbiome variation in both healthy and people living with HIVMahin Ghorbani, Khaled Al-Manei, Sabrina Naud, et al.
Nature Medicine|January 18, 2022
Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variantYu Gao, Curtis Cai, Alba Grifoni, et al.
Cell Host & Microbe|May 26, 2023
Memory profiles distinguish cross-reactive and virus-specific T cell immunity to mpoxSarah Adamo, Yu Gao, Takuya Sekine, et al.
Molecular Therapy. Advances|May 15, 2026
A phase 1 clinical trial of a multi-antigen SARS-CoV DNA vaccine as a booster after dose three spike-based mRNA vaccinationsSoo Aleman, Gustaf Ahlén, Jingyi Yan, et al.
Science Immunology|December 8, 2023
SARS-CoV-2 vaccination enhances the effector qualities of spike-specific T cells induced by COVID-19Curtis Cai, Yu Gao, Sarah Adamo, et al.
Pageof 18

Showing results (141-150 of 175) with videos related to

Sort By:
Pageof 18
BMJ Open|July 6, 2021
Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19Anders Kjellberg, Johan Douglas, Michael T Pawlik, et al.
Ebiomedicine|February 20, 2026
High-dimensional single-cell analyses reveal neutrophil heterogeneity in guttate psoriasisAvinash Padhi, Anoop T Ambikan, Panagiotis Andriopoulos, et al.
Scientific Reports|November 24, 2020
Insights in the regulation of trimetylamine N-oxide production using a comparative biomimetic approach suggest a metabolic switch in hibernating bearsThomas Ebert, Johanna Painer, Peter Bergman, et al.
Infectious Diseases (London, England)|September 25, 2024
Risk of COVID-19 hospitalisation by HIV-status and SARS-CoV-2 vaccination status during pre- and post-Omicron era in a national register-based cohort study in SwedenIsabela Killander Möller, Pontus Hedberg, Philippe Wagner, et al.
Journal of Clinical Immunology|September 1, 2022
Three Adult Cases of STAT1 Gain-of-Function with Chronic Mucocutaneous Candidiasis Treated with JAK InhibitorsEmilie W Borgström, Marie Edvinsson, Lucía P Pérez, et al.
Frontiers in Immunology|January 27, 2023
Persistence of salivary antibody responses after COVID-19 vaccination is associated with oral microbiome variation in both healthy and people living with HIVMahin Ghorbani, Khaled Al-Manei, Sabrina Naud, et al.
Nature Medicine|January 18, 2022
Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variantYu Gao, Curtis Cai, Alba Grifoni, et al.
Cell Host & Microbe|May 26, 2023
Memory profiles distinguish cross-reactive and virus-specific T cell immunity to mpoxSarah Adamo, Yu Gao, Takuya Sekine, et al.
Molecular Therapy. Advances|May 15, 2026
A phase 1 clinical trial of a multi-antigen SARS-CoV DNA vaccine as a booster after dose three spike-based mRNA vaccinationsSoo Aleman, Gustaf Ahlén, Jingyi Yan, et al.
Science Immunology|December 8, 2023
SARS-CoV-2 vaccination enhances the effector qualities of spike-specific T cells induced by COVID-19Curtis Cai, Yu Gao, Sarah Adamo, et al.
Pageof 18